1 / 26

Joint Hospital Surgical Ground Round 17-7-2010

Joint Hospital Surgical Ground Round 17-7-2010. The Management of Mycotic Aneurysm. Chan Hoi Yee Princess Margaret Hospital. Mycotic Aneurysm. First case was described in 1885 by Osler

rock
Download Presentation

Joint Hospital Surgical Ground Round 17-7-2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Joint Hospital Surgical Ground Round 17-7-2010 The Management of Mycotic Aneurysm Chan Hoi Yee Princess Margaret Hospital

  2. Mycotic Aneurysm • First case was described in 1885 by Osler • Dilatation of aorta > 50% of the luminal diameter with signs of infection (biochemical markers or imaging) • infective aortic aneurysm, first used in 1975 • 0.7-2.6% aortic aneurysm are complicated by infection • 80% due to microbial arteritis (most commonly caused by Streptococcus and Samonella)

  3. Pathogenesis • Septic emboli lodged in vessel lumen • Inflammatory process outside vessel wall • Inoculation of bacteria at time of accidental arterial trauma • Self induced vascular manipulation • Intimal defect seeded by concurrent bacteremia

  4. Mycotic Aneurysm Infected Aortic Aneurysms: Aggressive Presentation, Complicated Early Outcome, but Durable Result. Gustavo S et al. J Vasc Surg 2001;34:900-8

  5. Presentation Classic triad: • Fever • Leukocytosis • Pulsatile mass Infected Aortic Aneurysms: Aggressive Presentation, Complicated Early Outcome, but Durable Result. Gustavo S et al. J Vasc Surg 2001;34:900-8

  6. Investigations Infected Aortic Aneurysms: Aggressive Presentation, Complicated Early Outcome, but Durable Result. Gustavo S et al. J Vasc Surg 2001;34:900-8

  7. CT imaging A Comparison of Computed Tomography, Magnetic Resonance Imaging, and Digital Subtraction Angiography Findings in the Diagnosis of Infected Aortic Aneurysm. MP Lin et al. J Comput Assist Tomogr. 2008;32:616-620

  8. Imaging A Comparison of Computed Tomography, Magnetic Resonance Imaging, and Digital Subtraction Angiography Findings in the Diagnosis of Infected Aortic Aneurysm. MP Lin et al. J Comput Assist Tomogr. 2008;32:616-620

  9. Treatment of Mycotic aneurysm Antibiotics vs Antibiotics + surgery

  10. Medical Treatment • Medical treatment: - more effective antibiotics - surgery carries high risk - salmonella infections: iv ceftriaxone 1000-2000gm Q12H - non-salmonella infections: according to the culture result and sensitivity test

  11. Medical Treatment Selective Medical Treatment of Infected Aneurysms of the Aorta in High Risk Patients. RB Hsu et al. J Vasc Surg 2009;49:66-70 In-hospital Mortality 50% Aneurysm Related Mortality 54.2%

  12. Surgical Treatment • Aneurysm resection + soft tissue debridement + extra-anatomical bypass (eg. Axillo-bifemoral bypass) • Aneurysm resection + debridement + in-situ graft repair • Endovascular stenting

  13. Combined Medical and Surgical Treatment P= 0.314 Infected Aortic Aneurysm: Clinical Outcome and Risk Factor Analysis. RB. Hsu et al. J Vasc Surg 2004;40:30-5

  14. Surgical Treatment • Clinical outcomes of 6137 patients who underwent aortic reconstruction for aortic aneurysms at Mayo Clinic between Jan 1976 to Jan 2000 were reviewed • 43 patients had mycotic aneurysms underwent aneurysm resection + debridement + extra-anatomic bypass (6) or in-situ aortic graft (35) • Operative mortality rate: 21 % ( in-situ repair (20%) vs extra-anatomic bypass (16%) ) Infected Aortic Aneurysms: Aggressive Presentation, Complicated Early Outcome, but Durable Results. Gustavo S et al. J Vasc Surg 2001;34:900-8

  15. Surgical Treatment Infected Aortic Aneurysms: Aggressive Presentation, Complicated Early Outcome, but Durable Results. Gustavo S et al. J Vasc Surg 2001;34:900-8 No difference in late graft complication

  16. Surgical Treatment • Disadvantages for aneurysm resection + debridement + extra-anatomical bypass : - late disruption of aortic stump (20%) due to persistent infection --> fetal - lower limb ischemia required amputation 20-29% - lower patency rates of axillary-femoral bypass (19-50%) - extra-anatomic reconstruction is difficult for thoracoabdominal aneurysms  Wide debridement of necrotic tissue + copious saline irrigation + in-situ repair with aortic graft Treatment of infected abdominal aortic aneurysms with extra-anatomic bypass, aneurysm excision and drainage. Taylor LM et al. Am J Surg. 98;155:655-8

  17. Surgical Treament Hospital mortality 5% Surgical Treatment for Primary Infected Aneurysm of the Descending Thoracic Aorta, Abdominal Aorta and Iliac Arteries.RB Hsu et al. J Vasc Surg 2002;36:746-50

  18. Surgical Treatment • No perioperative intestinal ischemia or peri-operative limb loss • Survival rate after mean follow-up period of 23.6 months: 84.2 % • No patient has graft infection during follow-up period Surgical Treatment for Primary Infected Aneurysm of the Descending Thoracic Aorta, Abdominal Aorta and Iliac Arteries. RB Hsu et al. J Vasc Surg 2002;36:746-50

  19. Endovascular Stenting • Permanent treatment • Bridge to open surgery • First report of successful case by Semba et al in 1998 • Can avoid: - large incisions - aortic clamping - need for massive blood transfusion

  20. Endovascular Stenting • Disadvantages: - aneurysm is not excised  facilitate re-infection, recurrent sepsis and infection of stent - no culture can be harvested from wall of aneurysms  could residual infection be overcome by antibiotics ???  would placement of foreign body in infective bed aggravate the infection ???

  21. Endovascular Stenting • A retrospective study included 48 patients from Jan 1998 to Jan 2007 with a mean follow-up period of 22 months • 30-day mortality rate: 10.4% due to sepsis or massive bleeding Outcome After Endovascular Stent Graft Treatment for Mycotic Aortic Aneurysm: A Systemic Review. DK Chung et al. J Vasc Surg 2007;46:906-12

  22. Endovascular Stenting Outcome After Endovascular Stent Graft Treatment for Mycotic Aortic Aneurysm: A Systemic Review. DK Chung et al. J Vasc Surg 2007;46:906-12 25% • age > 65 • ruptured aneurysm or fever • at presentation

  23. Duration of Post-operative antibiotics • Not well studied • 6-8 weeks to lifelong • No signs of infection  - fever subsided - low leukocytes count - low titer of CRP

  24. Conclusions • Rare disease • Reported hospital mortality rate after combined medical and surgical treatment was 16-44% • Classical surgical treatment was aneurysm resection + soft tissue debridement + extra-anatomical bypass • In-situ graft repair also showed good results (survival rate 82.4% without graft infection or other complication) • EVAR is the new trend of treatment • However, all studies only have small case number and results may not show clinically significance • Larger study with longer period of follow-up is required

  25. References • Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. Gustavo S et al. J Vasc Surg 2001;34:900-8 • A comparison of computed tomography, magnetic resonance imaging, and digital subtraction angiography findings iin the diagnosis of infected aortic aneurysm. MP Lin et al. J Comput Assist Tomogr 2008;32:616-620 • Selective medical treatment of infected aneurysms of the aorta in high risk patients. RB Hsu et al. J Vasc Surg 2009;49:66-70 • Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. RB Hsu et al. J Vasc Surg 2002:36;746-50 • Infected aortic aneurysm, a changing entity. Mario N. Gomes et al. Ann Surg 1992(5);435-442 • Outcome after endovacsular stent graft treatment for mycotic aortic aneurysm: a systemic review. CD Kan et al. J Vasc Surg 2007;46:906-12 • Infected aortic aneurysms: clinical outcome and risk factor analysis. RB Hsu et al. J Vasc Surg 2004;40:30-5

  26. Thank You

More Related